Drug Type Small molecule drug |
Synonyms Darunavir/TMC 41629, Darunavir/TMC-41629, Darunavir/TMC41629 + [1] |
Target |
Action inhibitors |
Mechanism HIV-1 pol inhibitors(Human immunodeficiency virus type 1 Pol protein inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC29H43N3O8S |
InChIKeyQWSHKNICRJHQCY-VBTXLZOXSA-N |
CAS Registry635728-49-3 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| HIV Infections | Phase 1 | - | 01 Nov 2008 |





